Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Invested CapitalReturn on SalesTimes Interest Earned

Burning Rock Biotech (BNR) Asset Utilization Ratio (2021 - 2025)

Historic Asset Utilization Ratio for Burning Rock Biotech (BNR) over the last 5 years, with Q3 2025 value amounting to 0.65.

  • Burning Rock Biotech's Asset Utilization Ratio rose 2847.75% to 0.65 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.65, marking a year-over-year increase of 2847.75%. This contributed to the annual value of 0.53 for FY2024, which is 3131.46% up from last year.
  • Latest data reveals that Burning Rock Biotech reported Asset Utilization Ratio of 0.65 as of Q3 2025, which was up 2847.75% from 0.64 recorded in Q2 2025.
  • Burning Rock Biotech's Asset Utilization Ratio's 5-year high stood at 0.65 during Q3 2025, with a 5-year trough of 0.15 in Q4 2021.
  • In the last 5 years, Burning Rock Biotech's Asset Utilization Ratio had a median value of 0.43 in 2023 and averaged 0.4.
  • Data for Burning Rock Biotech's Asset Utilization Ratio shows a peak YoY increase of 13131.41% (in 2022) and a maximum YoY decrease of 104.21% (in 2022) over the last 5 years.
  • Quarter analysis of 5 years shows Burning Rock Biotech's Asset Utilization Ratio stood at 0.15 in 2021, then surged by 131.31% to 0.35 in 2022, then skyrocketed by 40.06% to 0.49 in 2023, then increased by 11.19% to 0.55 in 2024, then increased by 19.2% to 0.65 in 2025.
  • Its last three reported values are 0.65 in Q3 2025, 0.64 for Q2 2025, and 0.61 during Q1 2025.